Very illiquid stock, hard to say how much further to drop, but i think it is way way over sold, partly due to its liquidity. 6 months down the track, I can see this being back over 1.70 IMHO.Good chance to buy in now for the medium term.Thoughts?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025